- Home
- AREB vs IBO Comparison
AREB vs IBO Comparison
Compare AREB & IBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AREB
- IBO
- Stock Information
- Founded
- AREB 2014
- IBO 2018
- Country
- AREB United States
- IBO United States
- Employees
- AREB N/A
- IBO N/A
- Industry
- AREB Plastic Products
- IBO
- Sector
- AREB Industrials
- IBO
- Exchange
- AREB Nasdaq
- IBO NYSE
- Market Cap
- AREB 5.7M
- IBO 5.1M
- IPO Year
- AREB N/A
- IBO 2024
- Fundamental
- Price
- AREB $1.40
- IBO $0.52
- Analyst Decision
- AREB
- IBO
- Analyst Count
- AREB 0
- IBO 0
- Target Price
- AREB N/A
- IBO N/A
- AVG Volume (30 Days)
- AREB 2.4M
- IBO 10.5M
- Earning Date
- AREB 05-15-2025
- IBO 05-14-2025
- Dividend Yield
- AREB N/A
- IBO N/A
- EPS Growth
- AREB N/A
- IBO N/A
- EPS
- AREB N/A
- IBO N/A
- Revenue
- AREB $9,887,755.00
- IBO N/A
- Revenue This Year
- AREB N/A
- IBO N/A
- Revenue Next Year
- AREB N/A
- IBO N/A
- P/E Ratio
- AREB N/A
- IBO N/A
- Revenue Growth
- AREB N/A
- IBO N/A
- 52 Week Low
- AREB $1.10
- IBO $0.37
- 52 Week High
- AREB $231.75
- IBO $6.17
- Technical
- Relative Strength Index (RSI)
- AREB 34.65
- IBO N/A
- Support Level
- AREB $2.20
- IBO N/A
- Resistance Level
- AREB $3.05
- IBO N/A
- Average True Range (ATR)
- AREB 0.25
- IBO 0.00
- MACD
- AREB 0.07
- IBO 0.00
- Stochastic Oscillator
- AREB 1.20
- IBO 0.00
About AREB American Rebel Holdings Inc.
American Rebel Holdings Inc develops self-defense, safe storage, and patriotic product areas using a wholesale distribution network, utilizing personal appearances, musical venue performances, as well as e-commerce and television. It designs, manufactures, and markets concealed carry products. It offers products ranging in Backpacks, jackets, coats, and Others. The Company views its operations and manages its business as one operating segment engaged in patriotic goods, comprised of safes, soft goods, and beer.
About IBO IMPACT BIOMEDICAL INC
Impact BioMedical Inc focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases. The company is also developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza. Its technologies inlcude Linebacker, Laetose, 3F, and Equivir.